Chris Nolet is a partner with Ernst & Young in Palo Alto, California. Nolet joined Ernst & Young in 2001 after more than 21 years with PricewaterhouseCoopers, where he was a Partner and Leader – North America West Life Sciences Industry Group. With Ernst & Young, Nolet serves a number of the firm’s premier clients, including Genentech and Affymetrix. In addition, he supports E&Y engagement teams and health sciences clients throughout California and the western United States.
Nolet has participated in numerous private and public equity offerings and provided due diligence, valuation, structuring and execution leadership in connection with mergers, acquisitions, and collaborations. In addition to directly serving a number of life sciences companies in the San Francisco Bay Area, Nolet regularly consults with clients and non-clients throughout the US with regard to assessing emerging industry developments and structuring collaborations and spin-offs. He is a member of the American Institute of Certified Public Accountants and the California State Society of CPAs.